Integrating Substantia Nigra Hyperechogenicity and Inflammation-Associated Biomarkers: A Classification Model for Staging Cognitive Impairment in Parkinson’s Disease
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Cognitive impairment (CI) is recognized as a debilitating complication of Parkinson’s disease (PD). This study was designed to develop a diagnostic classification model by integrating substantia nigra hyperechogenicity (SNH) and inflammationassociated biomarkers to evaluate its diagnostic performance in distinguishing PD CI stages. Methods: Between January, 2023 and May, 2024, 184 patients with PD who underwent transcranial sonography were prospectively enrolled. Based on Montreal Cognitive Assessment (MoCA) scores, participants were categorized into three groups: cognitive impairment (PD-CI, MoCA
Fields of Study & Subjects
Parkinson's Disease Mechanisms and Treatments
Dementia and Cognitive Impairment Research
Neurological diseases and metabolism
Publication details
- Journal / source
- Journal of Integrative Neuroscience
- Volume
- 25
- Issue
- 3
- Pages
- 46585–46585
- Publication date
- 9 March 2026
- Language
- EN